• LifeStance Health Group director Robert Bessler disclosed sale of 575,034 shares of common stock on May 12 at USD 8.02 per share.
• Sales were reported as indirect holdings through Vitthal LLC and Shama LLC.
• Indirect holdings following transactions were 986,931 shares in Vitthal LLC and 1,103,729 shares in Shama LLC.
• Filing also listed 57,619 shares held directly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeStance Health Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-224379), on May 14, 2026, and is solely responsible for the information contained therein.